CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-12 | JUNIUS DANIEL M Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +723 | 723 | ||
| 2021-05-12 | ESSIG STUART Director | Grant or award · Restricted Stock Unit | +224 | 224 | ||
| 2021-05-12 | ESSIG STUART Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +723 | 723 | ||
| 2021-05-12 | COLLINS Asha Director | Grant or award · Deferred Stock Unit | +224 | 333 | ||
| 2021-05-12 | COLLINS Asha Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +723 | 723 | ||
| 2021-05-12 | Claflin Bruce L. Director | Grant or award · Restricted Stock Unit | +224 | 2,552 | ||
| 2021-05-12 | Claflin Bruce L. Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +723 | 723 | ||
| 2021-05-12 | AYERS JONATHAN W Director | Grant or award · Restricted Stock Unit | +224 | 224 | ||
| 2021-05-12 | AYERS JONATHAN W Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +723 | 723 | ||
| 2021-05-10 | AYERS JONATHAN W Director | Sale | −510 | $541.01 | $276K | 653,703 |
| 2021-05-10 | AYERS JONATHAN W Director | Sale | −2 | $542.46 | $1K | 653,701 |
| 2021-04-30 | JUNIUS DANIEL M Director | Grant or award | +11 | $548.99 | $6K | 2,886 |
| 2021-04-30 | ESSIG STUART Director | Grant or award | +36 | $548.99 | $20K | 1,029 |
| 2021-04-30 | COLLINS Asha Director | Grant or award | +36 | $548.99 | $20K | 78 |
| 2021-02-26 | TWIGGE GIOVANI Senior Vice President | Exercise or conversion | +3,227 | $67.85 | $219K | 16,950 |
| 2021-02-26 | TWIGGE GIOVANI Senior Vice President | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −3,227 | 0 | ||
| 2021-02-25 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion | +1,476 | $67.85 | $100K | 19,903 |
| 2021-02-25 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion · Incentive Stock Option (right-to-buy) | −1,476 | 0 | ||
| 2021-02-23 | HENDERSON REBECCA M Director | Exercise or conversion | +3,046 | $160.28 | $488K | 17,742 |
| 2021-02-23 | HENDERSON REBECCA M Director | Sale | −3,046 | $513.41 | $1.6M | 14,696 |
Page 72 of 74 · 1,474 trades